What is the dosage range for dopamine infusion in bradycardia?

What is the dosage range for dopamine infusion in bradycardia?

• A. 2-20 mcg/kg/min
• B. 5-15 mcg/kg/min
• C. 1-3 mcg/kg/min
• D. 20-40 mcg/kg/min

Answer: (A)

In bradycardia with hemodynamic compromise, dopamine dosing is used with a broad, titratable range because its effects depend on the infusion rate. At lower doses it primarily provides beta-1 stimulation (increasing heart rate and contractility) with some dopaminergic effects, while at higher doses it adds alpha-adrenergic vasoconstriction to raise blood pressure. This combination helps both improve heart rate and boost perfusion. The recommended range of 2-20 mcg/kg/min encompasses these phases: starting around the low end enhances chronotropy and inotropy, and titrating up toward the higher end provides sufficient vasoconstriction to improve blood pressure if needed. That flexibility is why this range best fits the goal of stabilizing bradycardia with hypotension. Smaller ranges like 1-3 mcg/kg/min mainly emphasize renal/dopaminergic effects with minimal impact on heart rate, which isn’t ideal for bradycardia. A mid-range like 5-15 mcg/kg/min is reasonable but narrower and may not fully address hypotension in all patients. A very high range like 20-40 mcg/kg/min increases the risk of excessive vasoconstriction and tachyarrhythmias, making it less appropriate as an initial titration target.

In bradycardia with hemodynamic compromise, dopamine dosing is used with a broad, titratable range because its effects depend on the infusion rate. At lower doses it primarily provides beta-1 stimulation (increasing heart rate and contractility) with some dopaminergic effects, while at higher doses it adds alpha-adrenergic vasoconstriction to raise blood pressure. This combination helps both improve heart rate and boost perfusion.

The recommended range of 2-20 mcg/kg/min encompasses these phases: starting around the low end enhances chronotropy and inotropy, and titrating up toward the higher end provides sufficient vasoconstriction to improve blood pressure if needed. That flexibility is why this range best fits the goal of stabilizing bradycardia with hypotension.

Smaller ranges like 1-3 mcg/kg/min mainly emphasize renal/dopaminergic effects with minimal impact on heart rate, which isn’t ideal for bradycardia. A mid-range like 5-15 mcg/kg/min is reasonable but narrower and may not fully address hypotension in all patients. A very high range like 20-40 mcg/kg/min increases the risk of excessive vasoconstriction and tachyarrhythmias, making it less appropriate as an initial titration target.